Abstract
The biological effects of 17β-estradiol (E2) are mediated by the two estrogen receptor (ER) isoforms ERα and ERβ. These receptors are ligand-inducible transcription factors that belong to the nuclear receptor superfamily. These receptors are also targets for a broad range of natural and synthetic compounds that induce ER activity, including dietary compounds, pharmaceuticals, and various types of environmental pollutants such as bisphenols and polychlorinated hydroxy-biphenyls. Here, we study the effect of the combustion byproduct 3-methylcholanthrene (3-MC) on ERα and ERβ. 3-MC is a compound identified previously as an activator of the aryl hydrocarbon receptor (AhR). Activation of AhR is traditionally associated with an inhibition of the E2 signaling network. In this study, we demonstrate that 3-MC is a cell-specific activator or inhibitor of E2 signaling pathways. We show that 3-MC acts as a repressor in some cells, presumably via the AhR, whereas it is a potent activator of ER activity in other cells. It is interesting that we demonstrate that the estrogenic effects of 3-MC are dependent on the ability of cells to metabolize parental 3-MC to alternative compounds. In summary, our results suggest that exposure to AhR ligands like 3-MC can lead to either activation or repression of E2 signaling, depending on the cellular context.
Footnotes
-
This work was supported by the Swedish Cancer Fund, the Swedish Research Council, and the European Union-funded CASCADE Network of Excellence.
-
ABBREVIATIONS: ER, estrogen receptor; 3-MC, 3-methylcholanthrene; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; LBD, ligand binding domain; AhR, aryl hydrocarbon receptor; E2, 17β-estradiol; NR, nuclear receptor; SPA, scintillation proximity assay; FCS, fetal calf serum; PCR, polymerase chain reaction; siRNA, short inhibitory RNA; DES, diethylstilbestrol; RT-PCR, real-time polymerase chain reaction; BaP, benzo(a)pyrene; 4-OHT, 4-OH-tamoxifen; ARNT, aryl hydrocarbon receptor nuclear translocator; HPLC, high-performance liquid chromatography; ERE, estrogen-response element; ICI, ICI 182,780, fulvestrant; β-gal, β-galactoside.
-
↵ The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
- Received March 26, 2007.
- Accepted November 14, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|